Roche granted Oswaldo Cruz Foundation rights to produce generic CellCept mycophenolate mofetil in Brazil

Roche

Switzerland / Large-Cap Biopharma (>=$50 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Oswaldo Cruz Foundation

Brazil / Non-Profit or Major Disease Foundation

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced